Dr. Mehta on Stem Cell Transplant in Multiple Myeloma

Jayesh Mehta, MD
Published: Friday, Nov 10, 2017



Jayesh Mehta, MD, professor of medicine (hematology and oncology), Feinberg School of Medicine, discusses stem cell transplant in multiple myeloma.

Many people do not like stem cell transplantation, but studies show that eliminating it from treatment only hurts the patient, says Mehta.

With curable diseases with different pathways, it is acceptable to choose 1 form of treatment over another, but that is not the case for incurable diseases, explains Mehta.


Jayesh Mehta, MD, professor of medicine (hematology and oncology), Feinberg School of Medicine, discusses stem cell transplant in multiple myeloma.

Many people do not like stem cell transplantation, but studies show that eliminating it from treatment only hurts the patient, says Mehta.

With curable diseases with different pathways, it is acceptable to choose 1 form of treatment over another, but that is not the case for incurable diseases, explains Mehta.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Choosing Therapies for Patients with EGFR-Mutant Lung Cancers: More Options... More Decisions... Better OutcomesFeb 28, 20182.0
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x